Hemostasis Analyzers Market Size Worth $6,490.24 Million, Globally, by 2028 at 9.5% CAGR - Exclusive Report by The Insight Partners

The Hemostasis Analyzers Market Size is driven by high prevalence of cardiovascular diseases and the rise in the geriatric population. The laboratory analyzer segment held a larger market share in 2021, and expected to witness the highest CAGR during 2021-2028. The Asia Pacific is expected to be the fastest-growing region and is likely to expand at a high growth rate due to the rising development in the pharmaceutical sector.

News provided by

The Insight Partners

Jan 13, 2022, 05:30 ET

NEW YORK, Jan. 13, 2022 /PRNewswire/ -- According to the new market research report "Hemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type [Laboratory Analyzer (Automated Systems, Semi-Automated Systems, and Manual Systems) and Point-of-Care Testing Systems], Test [Activated Partial Thromboplastin Time, D-Dimer Test, Fibrinogen Test, Prothrombin Time (PT) Test, and Others], and End User (Hospitals/Clinics, Independent Diagnostic Laboratories, Home Care Setting, and Others)", published by The Insight Partners, the global hemostasis analyzers market is projected to reach US$ 6,490.24 million by 2028 from US$ 3,440.66 million in 2021; it is expected to register a CAGR of 9.5% from 2021 to 2028.

Get Exclusive Sample Pages of Hemostasis Analyzers Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at https://www.theinsightpartners.com/sample/TIPRE00016709/

Report Coverage	Details
Market Size Value in	US$ 3,440.66 million in 2021
Market Size Value by	US$ 6,490.24 million by 2028
Growth rate	CAGR of 9.5% from 2021 to 2028.
Forecast Period	2021-2028
Base Year	2021
No. of Pages	188
No. Tables	111
No. of Charts & Figures	77
Historical data available	Yes
Segments covered	Product Type, Test, and End User
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Report coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Hemostasis Analyzers Market: Competitive Landscape and Key Developments

Siemens AG; Instrumentation Laboratory; Abbott; Sysmex Corporation; Nihon Kohden Corporation; Thermo Fisher Scientific, Inc.; Roche Diagnostics; Diagnostica Stago; Helena Laboratories; and International Technidyne Corporation are among the key companies operating in the hemostasis analyzers market. Leading players are focusing on the launch of products, expansion and diversification of their market presence, and acquisition of new customer base, thereby tapping prevailing business opportunities.

In August 2021, Siemens Healthineers launched Sysmex CN-3000 and CN-6000 Hemostasis Systems.

Inquiry Before Buying: https://www.theinsightpartners.com/inquiry/TIPRE00016709/

In North America, the US primarily holds the hemostasis analyzers market. The growth of the Hemostasis Analyzers Market in the US can be attributed to increasing organic developments by the market players, rising awareness among consumers for treatment, and increasing prevalence of chronic illnesses like blood disorders and cardiovascular diseases.

Hemostasis analyzers provide a quick and easy measurement of blood platelet levels. A coagulation test could help detect and prevent blood clots that could cause a heart attack. A coagulation analyzer can measure the speed of the coagulation pathway and the amounts of thrombolin and thromboplastin in less than a few minutes.

Cardiovascular diseases (CVDs) are likely to remain the most significant cause of morbidity and mortality worldwide. The CVDs are disorders of the heart and blood vessels and include cerebrovascular disease, coronary heart disease, rheumatic heart disease, and other conditions. Some lifestyle-related issues that lead to cardiovascular diseases and difficulties are tobacco use, unhealthy diet, and physical inactivity. They increase the risk of heart attacks and strokes. Other risk factors for cardiovascular diseases are high blood pressure, diabetes, and increased cholesterol levels. According to the World Health Organization (WHO), cardiovascular diseases are the number one cause of death globally.

Speak to Analyst: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00016709/

Based on product type, the hemostasis analyzers market is segmented into facial laboratory analyzers and point-of-care testing systems. The laboratory analyzer segment held a larger market share in 2021, and it is also expected to witness a higher CAGR from 2021 to 2028. Based on test, the hemostasis analyzers market is segmented into activated partial thromboplastin time, D-Dimer test, fibrinogen test, prothrombin time test, and others. The Prothrombin Time Test segment held the largest share of the market in 2021, and it is expected to register the highest CAGR during the forecast period.

High Prevalence of Cardiovascular Diseases Boost Market Growth:

Atrial fibrillation is the most common type of heart disorder, where the heart beats too fast, too slow, or irregularly. The Centers for Disease Control and Prevention (CDC) estimated that around 2.7–6.1 million people suffer from AFib in the US. In 2017, around 166,793 death certificates mentioned AFib and were the leading cause of death in 26,077 cases. Every year over 454,000 hospitalizations were due to AFib in the US, and about 158,000 deaths occur due to atrial fibrillation.

Buy Premium Copy of Hemostasis Analyzers Market Size, Share, Revenue, Strategic Insights and Forecasts 2021-2028 Research Report at https://www.theinsightpartners.com/buy/TIPRE00016709/

Hemostasis Analyzers Market: Segmental Overview

Based on end-user, the hemostasis analyzers market is segmented into hospitals/clinics, independent diagnostic laboratories, home care settings, and others. The hospitals/clinics segment was the largest shareholder in the market in 2021, and the independent diagnostic laboratories segment is expected to register the highest CAGR during 2021–2028.

Browse Adjoining Reports:

Generic Hematology Analyzers And Reagents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Hematology Analysers, Hemostasis Analysers, Plasma Protein Analysers, Hemoglobin Analysers, Others); Application (Anemia, Blood Cancers, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, Others); End User (Hospitals, Clinical Laboratories, Nursing Homes)

Hematology Analyzers and Reagents Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product and Service (Hematology Products and Services, Hemostasis Products and Services, Immunohematology Products and Services); Application (Anemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, Other Applications); End User (Hospital Laboratories, Commercial Service Providers, Government Reference Laboratories, Research and Academic Institutes), and Geography

Portable Hemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Systems (Automated system, Semi- automated system); Technology (Optical, Mechanical, Others); End-User (Clinical Laboratory, Hospitals, Others) and Geography

Hemostasis Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Topical Hemostasis Product, Infusible Hemostasis Product, Advanced Hemostasis Product); Application (Trauma, Surgery, Hemophilia, Myocardial Infarction, Others); End User (Hospitals, Clinics, Others)

Hemostasis Valve Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Type (Hemostasis Valve Y Connector, Double Y Connector Hemostasis Valve, One Handed); Application (Angiography, Angioplasty); End User (Hospitals, Ambulatory Surgery Centers) and Geography

Activated Clotting Time Testing Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Type (Point of Care, Clinical Laboratory Analyzer); Application (Cardiovascular and Vascular Surgery, ECMO, Cardiac Catheterization Laboratories, Critical Care Units, Hemodialysis Units); Technology (Optical Detection, Laser Based Detection, Fluorescent Based Detection); Test (Prothrombin Time, Fibrinogen,, Activated Partial Thromboplastin Time,, Activated Clotting Time, Others); End-User (Hospitals, Clinical Laboratories, Ambulatory Surgical Center, Academic and Research Institutes)

Point-of-Care Testing Devices Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Application (Blood glucose testing, Infectious disease testing, Coagulation testing, Pregnancy and fertility testing, Tumor markers testing, Others); End Users (Hospitals, Diagnostic Centers, Others) and Geography

Coagulation Analysers Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Product ( Clinical Laboratory Analysers and Point-of-care Testing Analysers ); Test ( Prothrombin Time Testing, Fibrinogen Testing, Activated Clotting Time Testing, Activated Partial Thromboplastin Time Testing, D-Dimer Testing, Platelet Function Tests, Anti-Factor Xa Tests, Heparin and Protamine Dose Response Tests for ACT and Other Coagulation Tests ); Technology ( Optical Technology, Mechanical Technology, Electrochemical

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: [email protected]
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/hemostasis-analyzers-market
More Research: https://www.openpr.com/news/archive/139407/The-Insight-Partners.html

SOURCE The Insight Partners